Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger CCHC domain-containing protein 13 (ZCCHC13) is a member of the zinc finger CCHC-type superfamily, characterized by the presence of a CCHC zinc finger motif (C-X2-C-X4-H-X4-C, known as a zinc-knuckle), which mediates high-affinity binding to single-stranded nucleic acids, especially RNA[1][3]. ZCCHC family proteins, including ZCCHC13, predominantly function as RNA-binding proteins involved in various aspects of RNA metabolism such as transcription, splicing, translation, and degradation[1][3]. ZCCHC13 is expressed in the central nervous system and cytoplasm, and is thought to be involved in the positive regulation of cytoplasmic translation, but precise specific functions and disease associations of ZCCHC13 remain poorly characterized. It is not commonly referenced as a direct therapeutic target, and there is no evidence for direct drug interactions or biomarker utility at this time[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger CCHC domain-containing protein 13 (ZCCHC13).